Sigilon Therapeutics Inc. (SGTX)
NASDAQ: SGTX
· Real-Time Price · USD
22.47
-0.59 (-2.56%)
At close: Aug 10, 2023, 10:00 PM
Sigilon Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -30.24M | -37.08M | -43.56M | -54.62M | -66.11M | -72.2M | -77.31M | -74.75M | -67.79M | -60.85M |
Depreciation & Amortization | 1.26M | 1.26M | 1.26M | 1.25M | 1.24M | 1.19M | 1.12M | 1.04M | 954K | 899K |
Stock-Based Compensation | 5.46M | 5.63M | 5.9M | 5.64M | 5.81M | 6.06M | 6.15M | 6.22M | 5.45M | 4.16M |
Other Working Capital | -9.98M | -13.36M | -10.4M | -11.31M | -11M | -9.88M | -14.25M | -18.74M | -14.73M | -16.17M |
Other Non-Cash Items | 3.92M | 3.91M | 4.17M | 4.48M | 4.82M | 5.08M | 5.06M | 5.64M | 5.41M | 4.92M |
Deferred Income Tax | 205K | n/a | 15K | 18K | 18K | 18K | 3K | 600K | 953K | 952K |
Change in Working Capital | -13.37M | -17.12M | -19.27M | -18.41M | -19.79M | -15.37M | -13.42M | -16.3M | -12.82M | -18.25M |
Operating Cash Flow | -32.76M | -43.39M | -51.47M | -61.64M | -74.01M | -75.22M | -78.41M | -78.15M | -68.8M | -69.12M |
Capital Expenditures | -521K | -491K | -537K | -814K | -1.34M | -1.94M | -1.83M | -2.03M | -1.71M | -1.07M |
Cash Acquisitions | 0.48 | 0.48 | 0.48 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 34.15M | 22.82M | -43 | -42.52M | -41.04M | -22.82M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 47.21M | 43.34M | 30.75M | 12.75M | 3M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -42.41M | -42.29M | -42.29M | -16.05M | -16.06M | -16.23M | -16.23M | n/a | n/a | n/a |
Investing Cash Flow | 38.43M | 23.37M | -12.08M | -46.64M | -55.44M | -40.99M | -18.06M | -2.03M | -1.71M | -1.07M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -20.66M | -3.3M | -1.61M | 718K | 705K | 705K | 180K | 157.27M | 161.85M | 161.85M |
Financial Cash Flow | -20.66M | -3.3M | -1.61M | 718K | 1.59M | 2.08M | 1.55M | 158.64M | 162.34M | 161.85M |
Net Cash Flow | -15M | -23.31M | -65.16M | -107.56M | -127.86M | -114.13M | -94.91M | 78.47M | 91.83M | 91.66M |
Free Cash Flow | -33.28M | -43.88M | -52.01M | -62.45M | -75.36M | -77.16M | -80.24M | -80.18M | -70.51M | -70.19M |